EVALUATE

Clinical trials for EVALUATE explained in plain language.

Never miss a new study

Get alerted when new EVALUATE trials appear

Sign up with your email to follow new studies for EVALUATE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Can a new drug shrink Hard-to-Treat adrenal tumors?

Disease control Not yet recruiting

This phase 2 trial is testing whether the drug ivonescimab can help control advanced or metastatic adrenal cancers, specifically adrenocortical carcinoma (ACC) and pheochromocytoma/paraganglioma (PPGL), that have not responded to prior treatment. About 20 adults with these rare c…

Matched conditions: EVALUATE

Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Aug 05, 2026 00:00 UTC

EVALUATE

Get alerted when new EVALUATE trials appear

Can a new drug shrink Hard-to-Treat adrenal tumors?